Literature DB >> 12966490

Osteonecrosis of the jaws associated with cancer chemotherapy.

J Wang1, N M Goodger, M A Pogrel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12966490     DOI： 10.1016/s0278-2391(03)00328-8

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN： 0278-2391            Impact factor:   1.895


× No keyword cloud information.
  59 in total

1.  Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws.

Authors:  Thomas Mücke; Janett Koschinski; Herbert Deppe; Stefan Wagenpfeil; Christoph Pautke; David A Mitchell; Klaus-Dietrich Wolff; Frank Hölzle
Journal:  J Cancer Res Clin Oncol       Date:  2010-10-07       Impact factor: 4.553

Review 2.  Osteonecrosis of the jaw induced by clodronate, an alkylbiphosphonate: case report and literature review.

Authors:  Sabrina Crépin; Marie-Laure Laroche; Bernard Sarry; Louis Merle
Journal:  Eur J Clin Pharmacol       Date:  2010-05-01       Impact factor: 2.953

3.  Osteonecrosis of maxilla secondary to bisphosphonate therapy: a case report.

Authors:  Trupti Kolur; Sanjiv C Nair; Balasubramanya Kumar
Journal:  J Maxillofac Oral Surg       Date:  2011-12-21

4.  [Osteonecrosis of the jaws as a possible adverse effect of the use of bisphosphonates].

Authors:  S Hoefert; H Eufinger
Journal:  Mund Kiefer Gesichtschir       Date:  2005-07

5.  Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer.

Authors:  Salvatore Ruggiero; Julie Gralow; Robert E Marx; Ana O Hoff; Mark M Schubert; Joseph M Huryn; Bela Toth; Kathryn Damato; Vicente Valero
Journal:  J Oncol Pract       Date:  2006-01       Impact factor: 3.840

6.  Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.

Authors:  Jeanny B Aragon-Ching; Yang-Min Ning; Clara C Chen; Lea Latham; Jean-Pierre Guadagnini; James L Gulley; Philip M Arlen; John J Wright; Howard Parnes; William D Figg; William L Dahut
Journal:  Cancer Invest       Date:  2009-02       Impact factor: 2.176

Review 7.  Pathologic fractures in bisphosphonate-related osteonecrosis of the jaw-review of the literature and review of our own cases.

Authors:  Sven Otto; Christoph Pautke; Sigurd Hafner; Ronny Hesse; Lea Franziska Reichardt; Gerson Mast; Michael Ehrenfeld; Carl-Peter Cornelius
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2013-05-31

Review 8.  Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors.

Authors:  Jason T Wan; Douglas M Sheeley; Martha J Somerman; Janice S Lee
Journal:  Bone Res       Date:  2020-03-11       Impact factor: 13.567

9.  Bisphosphonate-related osteonecrosis of the jaw: clinical correlations with computerized tomography presentation.

Authors:  Sharon Elad; Moshe J Gomori; Noa Ben-Ami; Silvina Friedlander-Barenboim; Eran Regev; Towy S Lazarovici; Noam Yarom
Journal:  Clin Oral Investig       Date:  2009-07-15       Impact factor: 3.573

10.  Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up.

Authors:  Philipp Stockmann; Eleftherios Vairaktaris; Falk Wehrhan; Martin Seiss; Stephan Schwarz; Bernd Spriewald; Friedrich-Wilhelm Neukam; Emeka Nkenke
Journal:  Support Care Cancer       Date:  2009-07-17       Impact factor: 3.603
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.